Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (182233) 182233
Magazine Article (847) 847
Book Chapter (144) 144
Book / eBook (106) 106
Conference Proceeding (87) 87
Web Resource (56) 56
Publication (40) 40
Newsletter (25) 25
Dissertation (17) 17
Reference (13) 13
Streaming Video (7) 7
Newspaper Article (2) 2
Book Review (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (175935) 175935
combined modality therapy (161601) 161601
female (103608) 103608
science & technology (100008) 100008
life sciences & biomedicine (98987) 98987
male (94510) 94510
middle aged (75896) 75896
adult (68771) 68771
aged (56505) 56505
biological and medical sciences (45381) 45381
medical sciences (45015) 45015
treatment outcome (42447) 42447
oncology (37480) 37480
antineoplastic combined chemotherapy protocols - therapeutic use (30579) 30579
follow-up studies (25361) 25361
prognosis (24907) 24907
adolescent (23795) 23795
surgery (22142) 22142
retrospective studies (21206) 21206
neoplasm staging (20750) 20750
abridged index medicus (18389) 18389
child (18003) 18003
aged, 80 and over (17561) 17561
chemotherapy (17535) 17535
survival rate (16364) 16364
cancer (15693) 15693
care and treatment (15464) 15464
tumors (15100) 15100
radiotherapy (12691) 12691
animals (12267) 12267
pharmacology. drug treatments (11166) 11166
time factors (10731) 10731
survival analysis (10551) 10551
child, preschool (10453) 10453
antineoplastic agents - therapeutic use (10333) 10333
risk factors (9596) 9596
medicine & public health (9378) 9378
antineoplastic agents (9260) 9260
prospective studies (8966) 8966
disease-free survival (8604) 8604
radiotherapy dosage (8475) 8475
young adult (8448) 8448
chemotherapy, adjuvant (8152) 8152
combined modality therapy - methods (8050) 8050
hematology (7999) 7999
health aspects (7335) 7335
cisplatin - administration & dosage (7295) 7295
research (7245) 7245
recurrence (7136) 7136
analysis (7072) 7072
infant (7044) 7044
radiology, nuclear medicine & medical imaging (7028) 7028
general & internal medicine (7021) 7021
neurosciences & neurology (6936) 6936
tomography, x-ray computed (6871) 6871
antineoplastic combined chemotherapy protocols - adverse effects (6451) 6451
clinical neurology (6118) 6118
medicine, general & internal (6048) 6048
remission induction (6025) 6025
clinical trials as topic (5838) 5838
lymphatic metastasis (5831) 5831
psychiatry (5603) 5603
diagnosis, differential (5551) 5551
pediatrics (5494) 5494
radiotherapy, adjuvant (5481) 5481
antineoplastic combined chemotherapy protocols - administration & dosage (5398) 5398
fluorouracil - administration & dosage (5376) 5376
risk assessment (5308) 5308
mice (5295) 5295
neoplasm recurrence, local (5226) 5226
magnetic resonance imaging (5099) 5099
cardiovascular system & cardiology (4869) 4869
breast neoplasms - therapy (4818) 4818
patients (4817) 4817
breast neoplasms - pathology (4722) 4722
quality of life (4693) 4693
doxorubicin - administration & dosage (4629) 4629
severity of illness index (4620) 4620
randomized controlled trials as topic (4604) 4604
cyclophosphamide - administration & dosage (4592) 4592
hematology, oncology and palliative medicine (4548) 4548
drug administration schedule (4534) 4534
breast cancer (4524) 4524
radiation therapy (4508) 4508
breast neoplasms - surgery (4479) 4479
drug therapy (4456) 4456
metastasis (4359) 4359
carcinoma, squamous cell - radiotherapy (4256) 4256
neoplasm metastasis (4189) 4189
lung neoplasms - drug therapy (4154) 4154
psychology. psychoanalysis. psychiatry (4087) 4087
carcinoma, squamous cell - therapy (4043) 4043
drug therapy, combination (4001) 4001
immunotherapy (3995) 3995
breast neoplasms - drug therapy (3963) 3963
clinical trials (3949) 3949
disease progression (3897) 3897
lung neoplasms - therapy (3887) 3887
gynecology. andrology. obstetrics (3876) 3876
cardiac & cardiovascular systems (3858) 3858
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (67) 67
Online Resources - Online (51) 51
Collection Dvlpm't (Acquisitions) - Vendor file (17) 17
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
UofT at Mississauga - Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Scarborough Hospital - Online (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Online (1) 1
Lakeridge Health Sciences - Online (1) 1
Providence Healthcare - Reference (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Sunnybrook Stacks (1) 1
Stacks (1) 1
Sunnybrook Health Sciences Centre - Oshawa (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (147610) 147610
German (14153) 14153
Russian (8208) 8208
Japanese (6429) 6429
French (5090) 5090
Spanish (3165) 3165
Chinese (2638) 2638
Italian (1568) 1568
Polish (762) 762
Dutch (497) 497
Portuguese (444) 444
Ukrainian (256) 256
Romanian (233) 233
Bulgarian (225) 225
Finnish (210) 210
Czech (184) 184
Hungarian (165) 165
Danish (144) 144
Hebrew (121) 121
Norwegian (92) 92
Turkish (77) 77
Korean (54) 54
Swedish (53) 53
Serbian (51) 51
Croatian (40) 40
Slovak (29) 29
Lithuanian (22) 22
Icelandic (10) 10
Greek (5) 5
Bosnian (4) 4
Afrikaans (3) 3
Arabic (1) 1
Azerbaijani (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Ultrasmall Biocompatible WO3−x Nanodots for Multi‐Modality Imaging and Combined Therapy of Cancers
by Wen, Ling and Chen, Ling and Zheng, Shimin and Zeng, Jianfeng and Duan, Guangxin and Wang, Yong and Wang, Guanglin and Chai, Zhifang and Li, Zhen and Gao, Mingyuan
Advanced materials (Weinheim), ISSN 0935-9648, 07/2016, Volume 28, Issue 25, pp. 5072 - 5079
multi‐modality imaging | tungsten oxide | combined tumor therapy | radiation sensitization | ultrasmall nanodots | Tungsten oxide | Multi-modality imaging | Combined tumor therapy | Radiation sensitization | Ultrasmall nanodots | multi-modality imaging | Materials Science | Materials Science, Multidisciplinary | Physics, Condensed Matter | Science & Technology - Other Topics | Chemistry, Physical | Physics | Science & Technology | Physics, Applied | Physical Sciences | Chemistry | Nanoscience & Nanotechnology | Technology | Chemistry, Multidisciplinary | Multimodal Imaging | Humans | Tomography, X-Ray Computed | Nanostructures | Neoplasms | Tungsten - chemistry | Phototherapy | Care and treatment | Health aspects | Tungsten compounds | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Single modality versus dual modality treatment for trichotillomania: Sertraline, behavioral therapy, or both?
by Dougherty, Darin D and Loh, Rebecca and Jenike, Michael A and Keuthen, Nancy J
The journal of clinical psychiatry, ISSN 0160-6689, 2006, Volume 67, Issue 7, pp. 1086 - 1092
Psychology, Clinical | Social Sciences | Life Sciences & Biomedicine | Psychiatry | Psychology | Science & Technology | Miscellaneous | Psychology. Psychoanalysis. Psychiatry | Dermatology | Hair and nails disorders | Adult and adolescent clinical studies | Biological and medical sciences | Medical sciences | Neuropharmacology | Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) | Psychopharmacology | Pharmacology. Drug treatments | Psychopathology. Psychiatry | Behavior therapy. Cognitive therapy | Treatments | Diagnostic and Statistical Manual of Mental Disorders | Trichotillomania - drug therapy | Double-Blind Method | Humans | Serotonin Uptake Inhibitors - therapeutic use | Male | Treatment Outcome | Combined Modality Therapy | Trichotillomania - therapy | Cognitive Behavioral Therapy - methods | Psychiatric Status Rating Scales | Sertraline - therapeutic use | Placebos | Adult | Female | Trichotillomania - diagnosis | Longitudinal Studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis
by Rusthoven, Chad G and Koshy, Matthew and Sher, David J and Ney, Douglas E and Gaspar, Laurie E and Jones, Bernard L and Karam, Sana D and Amini, Arya and Ormond, D. Ryan and Youssef, A. Samy and Kavanagh, Brian D
JAMA neurology, ISSN 2168-6149, 05/2016, Volume 73, Issue 7, pp. 821 - 828
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Dacarbazine - therapeutic use | Humans | Databases, Factual - statistics & numerical data | Male | Treatment Outcome | Combined Modality Therapy | Brain Neoplasms - drug therapy | Glioblastoma - radiotherapy | Antineoplastic Agents, Alkylating - therapeutic use | Dacarbazine - analogs & derivatives | Radiotherapy - methods | Aged, 80 and over | Female | Aged | Brain Neoplasms - radiotherapy | Glioblastoma - drug therapy | Cohort Studies | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
by Efstathiou, Jason A and Spiegel, Daphna Y and Shipley, William U and Heney, Niall M and Kaufman, Donald S and Niemierko, Andrzej and Coen, John J and Skowronski, Rafi Y and Paly, Jonathan J and McGovern, Francis J and Zietman, Anthony L
European urology, ISSN 0302-2838, 2011, Volume 61, Issue 4, pp. 705 - 711
Urology | Combined-modality therapy | Chemotherapy | Cystectomy | Radiation therapy | Bladder cancer | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Cystectomy - mortality | Multivariate Analysis | Urologic Surgical Procedures - mortality | Humans | Middle Aged | Male | Chemoradiotherapy, Adjuvant | Cystectomy - adverse effects | Time Factors | Urinary Bladder Neoplasms - pathology | Organ Sparing Treatments - adverse effects | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Boston | Urologic Surgical Procedures - adverse effects | Urinary Bladder Neoplasms - mortality | Risk Assessment | Neoplasm Invasiveness | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Disease-Free Survival | Hospitals, General | Urinary Bladder Neoplasms - therapy | Aged | Organ Sparing Treatments - mortality | Neoplasm Staging | Care and treatment | Nuclear radiation | Radiation | Radiotherapy | Health aspects | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Pulmonary recurrence predominates after combined modality therapy for rectal cancer: An original retrospective study
by Ding, Peirong and Liska, David and Tang, Peter and Shia, Jinru and Saltz, Leonard and Goodman, Karyn and Downey, Robert J and Nash, Garrett M and Temple, Larissa K and Paty, Philip B and Guillem, José G and Wong, W. Douglas and Weiser, Martin R
Annals of surgery, ISSN 0003-4932, 07/2012, Volume 256, Issue 1, pp. 111 - 116
Life Sciences & Biomedicine | Surgery | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Stomach. Duodenum. Small intestine. Colon. Rectum. Anus | Biological and medical sciences | General aspects | Medical sciences | Tumors | Multivariate Analysis | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Chemoradiotherapy, Adjuvant | Young Adult | Lung Neoplasms - secondary | Aged, 80 and over | Adult | Female | Rectal Neoplasms - pathology | Retrospective Studies | Liver Neoplasms - secondary | Radiotherapy Dosage | Neoplasm Invasiveness | Rectal Neoplasms - surgery | Risk Factors | Combined Modality Therapy | Rectal Neoplasms - therapy | Lung Neoplasms - epidemiology | Adolescent | Lung Neoplasms - diagnostic imaging | Aged | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Sonodynamic therapy‐assisted immunotherapy: A novel modality for cancer treatment
by Zhang, Qianyu and Bao, Cuixia and Cai, Xiaojun and Jin, Longwei and Sun, Lingling and Lang, Yuehong and Li, Libo
Cancer science, ISSN 1347-9032, 05/2018, Volume 109, Issue 5, pp. 1330 - 1345
sonodynamic therapy | cancer | abscopal effect | immune response | photodynamic therapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Cell Survival - drug effects | Humans | Liver Neoplasms - immunology | Combined Modality Therapy | Liver Neoplasms - therapy | Metalloporphyrins - pharmacology | Photochemotherapy | Ultrasonic Therapy - methods | Animals | Photosensitizing Agents | Metalloporphyrins - administration & dosage | Immunotherapy | Liver Neoplasms - metabolism | Calreticulin - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Care and treatment | Vaccination | Cancer | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy
by Kuo, Wen-Shuo and Chang, Yi-Ting and Cho, Keng-Chi and Chiu, Kuo-Chih and Lien, Chi-Hsiang and Yeh, Chen-Sheng and Chen, Shean-Jen
Biomaterials, ISSN 0142-9612, 2012, Volume 33, Issue 11, pp. 3270 - 3278
Advanced Basic Science | Dentistry | Indocyanine green | Gold nanorod | Photodestruction | Gold nanoparticles | Photostability | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Gold - chemistry | Lung Neoplasms - drug therapy | Nanostructures - ultrastructure | Low-Level Light Therapy - methods | Photochemotherapy - methods | Humans | Indocyanine Green - therapeutic use | Lung Neoplasms - pathology | Treatment Outcome | Combined Modality Therapy | Indocyanine Green - chemistry | Cell Line, Tumor | Gold - therapeutic use | Nanostructures - chemistry | Nanostructures - therapeutic use | Biological products | Photochemotherapy | Cancer | Biomedical engineering | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
by Stupp, Roger and Taillibert, Sophie and Kanner, Andrew A and Kesari, Santosh and Steinberg, David M and Toms, Steven A and Taylor, Lynne P and Lieberman, Frank and Silvani, Antonio and Fink, Karen L and Barnett, Gene H and Zhu, Jay-Jiguang and Henson, John W and Engelhard, Herbert H and Chen, Thomas C and Tran, David D and Sroubek, Jan and Tran, Nam D and Hottinger, Andreas F and Landolfi, Joseph and Desai, Rajiv and Caroli, Manuela and Kew, Yvonne and Honnorat, Jerome and Idbaih, Ahmed and Kirson, Eilon D and Weinberg, Uri and Palti, Yoram and Hegi, Monika E and Ram, Zvi
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dacarbazine - therapeutic use | United States | Humans | Middle Aged | Male | Chemoradiotherapy | Young Adult | Early Termination of Clinical Trials | Carmustine - therapeutic use | Maintenance Chemotherapy - methods | Dacarbazine - analogs & derivatives | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Republic of Korea | Europe | Combined Modality Therapy - adverse effects | Disease Progression | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - therapy | Canada | Disease-Free Survival | Electric Stimulation Therapy - methods | Electric Stimulation Therapy - adverse effects | Brain Neoplasms - therapy | Aged | Combined Modality Therapy - methods | Israel | Glioblastoma - mortality | Patient safety | Brain cancer | Medical treatment | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
by Devos, David and Moreau, Caroline and Devedjian, Jean Christophe and Kluza, Jérome and Petrault, Maud and Laloux, Charlotte and Jonneaux, Aurélie and Ryckewaert, Gilles and Garçon, Guillaume and Rouaix, Nathalie and Duhamel, Alain and Jissendi, Patrice and Dujardin, Kathy and Auger, Florent and Ravasi, Laura and Hopes, Lucie and Grolez, Guillaume and Firdaus, Wance and Sablonnière, Bernard and Strubi-Vuillaume, Isabelle and Zahr, Noel and Destée, Alain and Corvol, Jean-Christophe and Pöltl, Dominik and Leist, Marcel and Rose, Christian and Defebvre, Luc and Marchetti, Philippe and Cabantchik, Z. Ioav and Bordet, Régis
Antioxidants & redox signaling, ISSN 1523-0864, 07/2014, Volume 21, Issue 2, pp. 195 - 210
Original Research Communication | Biochemistry & Molecular Biology | Endocrinology & Metabolism | Life Sciences & Biomedicine | Science & Technology | Cell Line | Iron Chelating Agents - therapeutic use | Double-Blind Method | Humans | Mice, Inbred C57BL | Motor Activity - drug effects | Male | Combined Modality Therapy | Parkinson Disease - drug therapy | Iron - metabolism | Pyridones - administration & dosage | Pilot Projects | Animals | Iron Chelating Agents - administration & dosage | Mice | Parkinson Disease - metabolism | Pyridones - therapeutic use | Oxidative Stress - drug effects | Pyridones - pharmacology | Disease Models, Animal | Care and treatment | Iron | Parkinson's disease | Research | Chemical properties | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: A multi-institutional, long-term experience
by Perdonà, Sisto and Autorino, Riccardo and Damiano, Rocco and De Sio, Marco and Morrica, Brunello and Gallo, Luigi and Silvestro, Giustino and Farella, Antonio and De Placido, Sabino and Di Lorenzo, Giuseppe
Cancer, ISSN 0008-543X, 01/2008, Volume 112, Issue 1, pp. 76 - 83
Chemotherapy | Transurethral resection | Radiotherapy | Bladder cancer | Conservative treatment | Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Tumors | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Combined Modality Therapy - adverse effects | Urinary Bladder Neoplasms - surgery | Urinary Bladder Neoplasms - therapy | Survival Analysis | Adult | Female | Aged | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Care and treatment | Patient outcomes | Surgery | Combined modality therapy | Bladder | Research | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights